Zimmer Biomet reports fourth-quarter, full-year 2023 financial results
Click Here to Manage Email Alerts
Key takeaways:
- Zimmer Biomet released its fourth-quarter and full-year 2023 financial results.
- The company reported increased net sales in both the fourth quarter and full year of 2023.
Zimmer Biomet Holdings Inc. has announced increased net sales for the fourth quarter and full year of 2023, according to its latest financial report.
Zimmer Biomet reported $1.94 billion in net sales for the fourth quarter of 2023, an increase of 6.3% from the prior year period. The company also reported $7.394 billion in net sales for the full year of 2023, an increase of 6.5% from 2022. In addition, the company reported net earnings of $419.2 million for the fourth quarter of 2023 and $1.024 billion for the full year.
“We are pleased to conclude a successful year with strong fourth-quarter results driven by consistent execution, including a healthy second-half growth profile,” Ivan Tornos, president and CEO of Zimmer Biomet, said in the release. “I’m confident in our ability to carry our 2023 momentum into 2024 and to create further value for our stakeholders. As we look ahead, we remain laser focused on our priorities to advance people and culture, achieve operational excellence and drive innovation and diversification to deliver on our mission,” Tornos added.